0001209191-21-004142.txt : 20210119
0001209191-21-004142.hdr.sgml : 20210119
20210119203240
ACCESSION NUMBER: 0001209191-21-004142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210119
DATE AS OF CHANGE: 20210119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fischer Laurent
CENTRAL INDEX KEY: 0001379344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 21537126
MAIL ADDRESS:
STREET 1: C/O PANACOS PHARMACEUTICALS, INC.
STREET 2: 134 COOLIDGE AVENUE
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-272-6269
MAIL ADDRESS:
STREET 1: 800 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc.
DATE OF NAME CHANGE: 20100921
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-15
0
0001501756
Adverum Biotechnologies, Inc.
ADVM
0001379344
Fischer Laurent
C/O ADVERUM BIOTECHNOLOGIES, INC.
800 SAGINAW DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
CEO and Director
Common Stock
2021-01-15
4
P
0
8600
11.5338
A
16292
D
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $11.44 to $11.60. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Laurent D. Fischer, by /s/ Ron A. Metzger, Attorney-in-Fact.
2021-01-19